MedicinePharmacologyPharmacotherapyAntimicrobial PharmacologyChemotherapyParasitic Skin DiseaseAntifungal AgentsAntifungal PharmacologyAntifungal PharmacotherapyAntifungal TherapyProtozoal InfectionsSkin InfectionsAntileishmanial ChemotherapyAntileishmanial TreatmentChemotherapy Of Protozoan InfectionsItraconazole TherapyLeishmaniasis PathogenesisNew Antifungal AgentsOral Antifungal AgentsTreatment Of Leishmaniasis
The chemotherapy of leishmaniasis is still far from satisfactory. Itraconazole, one of the most recent azole antifungal agents, appears to be well tolerated in man. Two patients with cutaneous leishmaniasis (Leishmania tropica), contracted in Saudi Arabia, were treated orally for 2 months with itraconazole (100 mg/d). Both recovered without side effects or abnormalities in their main biologic parameters.
12
Itraconazole: Pharmacologic Studies in Animals and Humans
Herman Van Cauteren, J. Heykants, R. De Coster et al. · Clinical Infectious Diseases · 1987 · 131 citations
Topical Treatment of Cutaneous Leishmaniasis
J. El-On, R Livshin, Z. Even‐Paz et al. · Journal of Investigative Dermatology · 1986 · 119 citations